SlimSEB™. Turning Sugar into Fiber. Rethinking Metabolic Health.
You’ve heard us talk about SlimSEB™ before. We’ve been buzzing about it since the earliest data started rolling in, and for good reason.
SlimSEB™ is an advanced, research-backed blend of enzymes, probiotics and herbal extracts formulated to support gut, cardiovascular and metabolic health.*
What sets it apart isn’t the ingredient list. It’s the way it works. At the heart of SlimSEB™ is an innovative proprietary enzyme that does something remarkably simple and remarkably powerful: it converts a portion of consumed sugar into fiber during digestion.*
It’s a single action with the potential to influence blood sugar response, satiety, gut health, and cardiovascular and metabolic wellness in ways few ingredients can match.*
The Science Behind the Breakthrough
Let’s break it down.
- Sucrose, or table sugar, consists of two linked molecules: glucose and fructose.
- When SlimSEB™ encounters sucrose in the digestive tract, it breaks that bond and gets to work.
- Instead of allowing all the glucose to become available for rapid absorption, SlimSEB™ links glucose molecules together, creating slowly digestible and non-digestible glucan fibers called alternans. The result is a fundamental shift in how a portion of dietary sugar is processed.
- Fructose, meanwhile, continues to be processed more slowly, delivering sustained energy without the crash associated with fast-absorbing sugars
Put simply, SlimSEB™ helps transform sugar into functional fiber.
A Closer Look at Alternan Fibers
Alternan, the fibers resulting from the glucose bonds joining, have a unique structure made up of alternating α-1,3 and α-1,6 glycosidic bonds. Most digestive enzymes cannot pull these bonds apart, so the compounds behave more like dietary fiber than fast-absorbing sugar.
Research on alternan fibers has demonstrated a range of physiological benefits, including:
- Increased stool bulk & improved laxative properties*
- Stimulation of colonic fermentation*
- Healthier gut flora*
- Support for healthy total & LDL cholesterol levels*
- Reduced post-prandial blood glucose & insulin responses*
The prebiotic potential is equally compelling. Alternan-derived oligosaccharides have been shown to support the growth of beneficial bacteria, such as Bifidobacterium and Lactobacillus species.*
Studies show these oligosaccharides increase the production of short-chain fatty acids, with effects comparable to established prebiotics such as inulin.*
Safety data rounds out the picture, with research confirming that alternan oligosaccharides are safe and well-tolerated.*
Why This Matters for Formulators
Brands and product developers have been searching for clean, defensible ways to address the booming metabolic health and GLP-1 companion categories. SlimSEB™ answers that call with a mechanism that’s both scientifically credible and easy to communicate to end consumers.
SlimSEB™’s action on sugar speaks directly to some of today’s fastest-growing consumer segments. Think biohackers optimizing daily glucose curves, women navigating the metabolic shifts of perimenopause and menopause, individuals managing diabetes or wearing CGMs, and people with prediabetes working to keep it from progressing.
By converting a portion of consumed sugar into fiber, SlimSEB™ offers a range of benefits:
- Reduced sugar absorption
Less free glucose means less of it gets absorbed into the bloodstream*
- Fewer calories absorbed
Converting sugar to fiber means the body processes less as usable energy, supporting healthy weight management*
- Built-in prebiotic support
Fibers generated by SlimSEB™ act as food for beneficial gut bacteria, nourishing the microbiome*
- Healthy blood sugar support
SlimSEB™ supports glucose levels already within normal range and promotes a healthy metabolic response after meals*
- Satiety
Fiber formation in the gut contributes to a feeling of fullness, helping curb overconsumption*
From glucose response to gut health to appetite control, these combined benefits give formulators multiple angles to connect with health-conscious consumers, whether they’re counting macros, tracking a CGM or simply paying closer attention to how food makes them feel.
SlimSEB™ is not a single-benefit ingredient. It’s a multi-action, synbiotic approach to metabolic wellness that gives formulators a meaningful story to tell across an expanding range of consumer segments.*
Innovation Backed by Research
SlimSEB™ carries a growing body of clinical and laboratory evidence. It’s supported by 11 studies, including 8 clinicals.
Recently published studies demonstrate how it shapes post-meal glucose response, fits alongside GLP-1 use and moves cardiometabolic markers.*
Cardiometabolic Health (Clinical)
A newly published prospective, randomized, double-blind, parallel-controlled study followed 87 adults for 84 days. SlimSEB™ supported improvements in body weight, waist circumference, HbA1c, fasting insulin, total cholesterol, triglycerides and inflammation.*
Takeaway: Weight, blood sugar, lipids and inflammation moved together. SlimSEB™ supports the entire metabolic system, not a single biomarker.*
GLP-1 Companion (Clinical)
A 30-adult pilot study tracked stable GLP-1 users through 30 days of control, then 30 days of SlimSEB™. Participants showed gains in gut comfort, quality of life and body composition, with no adverse events.*
Takeaway: Published clinical evidence gives brands a strong foundation for formulating GLP-1 companion products.*
Dive deeper into SlimSEB™’s support for GLP-1 use!
Blood Sugar Support
In Vitro Study
Researchers simulated human digestion using the INFOGEST protocol and a typical fast-food meal. SlimSEB™ delivered a 19.4% reduction in available simple sugars by converting them into fiber-like oligosaccharides.*
Clinical Trial
A double-blind, randomized, crossover, placebo-controlled study followed 35 adults. SlimSEB™ led to a 16.90% reduction in glucose AUC (area under the curve) versus the control, with no adverse events reported.*
Takeaway: Lab and clinical data point in the same direction. SlimSEB™ cuts available sugars in the digestive tract and supports a healthier post-meal glucose response in people.*
Learn more about studies on SlimSEB™ and blood sugar!
Fresh Data, With More on the Way
Our most recently published studies show SlimSEB™ at work, from the digestive tract to the bloodstream, and more studies are in the works.
Strong science is part of the equation. Flexible formulation gets SlimSEB™ into the formats your customers already know and love.
A Formulation Designed for Flexibility
SlimSEB™ is a synergistic blend of digestive enzymes, probiotics and herbal extracts, such as green tea and mulberry leaf, designed to support a comprehensive approach to metabolic health.*
It formulates easily into:
- Capsules
- Powders
- Packets
- Sachets
Its versatility makes SlimSEB™ an excellent fit for metabolic health products, weight management solutions, cardiovascular support formulas and the fast-growing GLP-1 companion category.*
Why We’re So Excited
True innovation in the enzyme and probiotic space is what gets us out of bed in the morning. A mechanism that turns ordinary dietary sugar into functional fiber represents a fundamentally different way of thinking about metabolic support.
More than a decade of research, development and validation have gone into bringing SlimSEB™ to market, and the result is an ingredient unlike anything currently available.
The applications are significant. The science is compelling. And we’re only beginning to uncover what’s possible.
The Next Chapter in Metabolic Health Innovation
Keep your eyes peeled. We’ll continue sharing additional clinical findings and exploring what this powerful ingredient could mean for the future of metabolic health formulations.
Ready to bring real science-backed innovation to your next wellness product? Now is the moment to get the conversation started.
To learn more about SlimSEB™ or talk through formulation opportunities, drop us an email or give us a call at (909) 613-1660. We’d love to think it through with you.
Sources
- Vaze, R., et al., 2024. Carbohydrate Research, 542, 109202.
- Rathi A, Chandan H, Vira C, Pore MP. Toxicology Research and Application. 2023;7. doi:10.1177/23978473231215122
- Rathi, A. et al. (2025). Advanced Enzymes Proprietary clinical study.
- Rathi, A. et al. (2026). Advanced Enzymes Proprietary clinical study.
- Rathi A, Pagare R, Agrawal M. Diabetes Res Open J. 2024; 10(1): 1-5.
- Rathi, A., Potale, S., & Rathi, V. L. (2026). International Journal of Clinical Trials, 13(1), 30–39